Morice sends us a message
Morice is his parents’ pride and joy. This two-year-old from the outskirts of Hanover, Germany, presents the classic X-linked form of CNM – a diagnosis that was reached only after a long and difficult journey. But instead of letting this devastating news get the better of them, Morice’s parents made a vow to never stop fighting for their son.
Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathies (CNM), a debilitating rare disease affecting children and young adults.